Ascendis Pharma AS • ASND

Capital at risk.

About Ascendis Pharma AS
Ticker
info
ASND
Trading on
info
NASDAQ
ISIN
info
US04351P1012
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Jan Moller Mikkelsen
Headquarters
info
Tuborg Boulevard 12, Hellerup, undefined, Denmark, 2900
Employees
info
1,017
Website
info
https://ascendispharma.com
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It also develops a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. Ascendis Pharma A/S was incorporated in 2006 and is headquartered in Hellerup, Denmark.
Metrics
BasicAdvanced
Market cap
info
$9.08B
P/E ratio
info
-
EPS
info
-$7.16
Dividend Yield
info
0.00%
Beta
info
0.54
Forward P/E ratio
info
0
EBIDTA
info
$-274M
Ex dividend date
info
-
Price & volume
Market cap
info
$9.08B
Average daily volume
info
0.5M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
24.96
Price to book
info
14.55
Earnings
EPS
info
-$7.16
EPS estimate (current quarter)
info
-$0.93
EPS estimate (next quarter)
info
-$1.30
EBITDA
info
$-274M
Revenues (TTM)
info
$364M
Revenues per share (TTM)
info
$6.28
Technicals
Beta
info
0.54
52-week High
info
$169.37
52-week Low
info
$111.09
50-day moving average
info
$147.48
200-day moving average
info
$136.69
Short ratio
info
9.75
Short %
info
8.62%
Management effectiveness
ROE (TTM)
info
818.43%
ROA (TTM)
info
17.38%
Profit margin
info
103.97%
Gross profit margin
info
$319M
Operating margin
info
0.22%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
26.30%
Share stats
Outstanding Shares
info
60.1M
Float
info
59.4M
Insiders %
info
0.78%
Institutions %
info
110.49%
Analyst Insights & forecasts
info

94% Buy

6% Hold

0% Sell

Based on information from 15 analysts.

Average price target

info
$219.06
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$2.30
-$1.50
53.33%
Q1 • 24Beat
-$2.11
-$1.46
44.52%
Q2 • 24Beat
-$1.72
-$1.89
8.99%
Q3 • 24Beat
-$0.64
-$0.93
31.38%
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$57.8M
$-99.2M
171.52%
Q3 • 24
$174M
$-38.5M
22.12%
Q4 • 24
200.72%
61.22%
87.10%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$1.09B
$1.19B
108.90%
Q3 • 24
$1.18B
$1.29B
108.96%
Q4 • 24
7.84%
7.90%
0.06%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
-
-
-
-
Q3 • 24
$-87.2M
$-0.4M
$0.1M
$-87.6M
Q4 • 24
-
-
NaN%
NaN%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Ascendis Pharma AS share?
Collapse

Ascendis Pharma AS shares are currently traded for undefined per share.

How many shares does Ascendis Pharma AS have?
Collapse

Ascendis Pharma AS currently has 60.1M shares.

Does Ascendis Pharma AS pay dividends?
Collapse

No, Ascendis Pharma AS doesn't pay dividends.

What is Ascendis Pharma AS 52 week high?
Collapse

Ascendis Pharma AS 52 week high is $169.37.

What is Ascendis Pharma AS 52 week low?
Collapse

Ascendis Pharma AS 52 week low is $111.09.

What is the 200-day moving average of Ascendis Pharma AS?
Collapse

Ascendis Pharma AS 200-day moving average is $136.69.

Who is Ascendis Pharma AS CEO?
Collapse

The CEO of Ascendis Pharma AS is Jan Moller Mikkelsen.

How many employees Ascendis Pharma AS has?
Collapse

Ascendis Pharma AS has 1,017 employees.

What is the market cap of Ascendis Pharma AS?
Collapse

The market cap of Ascendis Pharma AS is $9.08B.

What is the P/E of Ascendis Pharma AS?
Collapse

The current P/E of Ascendis Pharma AS is null.

What is the EPS of Ascendis Pharma AS?
Collapse

The EPS of Ascendis Pharma AS is -$7.16.

What is the PEG Ratio of Ascendis Pharma AS?
Collapse

The PEG Ratio of Ascendis Pharma AS is null.

What do analysts say about Ascendis Pharma AS?
Collapse

According to the analysts Ascendis Pharma AS is considered a buy.